TCBIO
BULLISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Ref P/E, P/B, and Graham Number of $81.89
- P/E of 5.56
- P/B of 0.29
- Current price is ~73% below Graham Number
Ref Growth rates
- 49% Earnings Growth YoY
- 19.1% Revenue Growth YoY
Ref Historical price performance
- Positive 1Y (+23%), 3Y (+36.5%), and 5Y (+18.9%) returns
- Recent technical trend is bearish
Ref Piotroski F-Score
- Piotroski F-Score of 4/9 is in the 'Stable' range
- F-Score is not in the 'Strong' (7-9) category
- Altman Z-Score data unavailable
Ref Yield and Dividend Rate
- High yield of 6.53%
- Payout ratio not provided for sustainability analysis
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for TCBIO and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
TCBIO
Texas Capital Bancshares, Inc.
Primary
|
+18.9% | +36.5% | +23.0% | +10.9% | +1.2% | +1.0% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Financial Services Sector Comparison
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-06 | STALLINGS ROBERT W | Director | Purchase | 25,500 | $579,200 |
| 2026-03-04 | STALLINGS ROBERT W | Director | Purchase | 45,000 | $1,000,950 |
| 2026-03-02 | STALLINGS ROBERT W | Director | Purchase | 25,000 | $555,850 |
| 2026-02-24 | STALLINGS ROBERT W | Director | Purchase | 40,000 | $888,000 |
| 2026-02-18 | STALLINGS ROBERT W | Director | Purchase | 10,000 | $221,280 |
| 2026-02-05 | STALLINGS ROBERT W | Director | Purchase | 16,885 | $360,579 |
| 2026-02-03 | STALLINGS ROBERT W | Director | Purchase | 4,115 | $86,760 |
| 2026-01-30 | STALLINGS ROBERT W | Director | Purchase | 7,000 | $146,445 |
| 2026-01-23 | STALLINGS ROBERT W | Director | Purchase | 2,000 | $41,820 |
| 2025-10-28 | STALLINGS ROBERT W | Director | Purchase | 5,000 | $104,150 |
| 2025-10-27 | STALLINGS ROBERT W | Director | Purchase | 15,000 | $309,500 |
Past News Coverage
Recent headlines mentioning TCBIO from our newsroom.